🩸Oncosema™️ is a purpose-driven company. Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient. 🩸Oncosema™️ is a deeptech start-up. We operate an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer. 🩸Oncosema™️ is focused on providing impactful tests for Oncology. ✔️Non-invasive ✔️Sensitive and specific ✔️Easy-to-use Oncosema™️ is a registred trade mark of Oncocellex.
| Website | https://www.oncosema.com |
| Employees | View employees |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Precision Oncology, Clinical Decision Support, Cancer Diagnostics, Data Driven Oncology, Non Invasive Diagnostics, Oncology Solutions, Cancer Biomarkers, Oncology Software, Tumor Analysis, Therapeutic Solutions, Cancer Research, Oncology Informatics, Cancer Treatment, Cancer Care, Digital Oncology, Medical Technology, Medical Devices, Patient Management, Healthcare Technology |
| Competitors | Exact Sciences, Guardant Health, Myriad Genetics, Foundation Medicine, Caris Life Sciences, NeoGenomics Laboratories, Invitae, Freenome, Caribou Biosciences, Strata Oncology +37 more (view full list) |
Looking for a particular OncoCellEx employee's phone or email?